Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics Statistics

Total Valuation

MLYS has a market cap or net worth of $3.38 billion. The enterprise value is $3.05 billion.

Market Cap	3.38B
Enterprise Value	3.05B

Important Dates

The next estimated earnings date is Monday, November 10, 2025, after market close.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

MLYS has 77.57 million shares outstanding. The number of shares has increased by 25.20% in one year.

Current Share Class	77.57M
Shares Outstanding	77.57M
Shares Change (YoY)	+25.20%
Shares Change (QoQ)	+23.11%
Owned by Insiders (%)	1.36%
Owned by Institutions (%)	64.49%
Float	54.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	9.13
P/TBV Ratio	10.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.12

Current Ratio	15.12
Quick Ratio	14.65
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.21% and return on invested capital (ROIC) is -42.05%.

Return on Equity (ROE)	-63.21%
Return on Assets (ROA)	-38.80%
Return on Invested Capital (ROIC)	-42.05%
Return on Capital Employed (ROCE)	-64.76%
Revenue Per Employee	n/a
Profits Per Employee	-$3.74M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +212.48% in the last 52 weeks. The beta is 0.40, so MLYS's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+212.48%
50-Day Moving Average	30.71
200-Day Moving Average	17.57
Relative Strength Index (RSI)	71.35
Average Volume (20 Days)	1,379,256

Short Selling Information

The latest short interest is 6.88 million, so 8.87% of the outstanding shares have been sold short.

Short Interest	6.88M
Short Previous Month	7.58M
Short % of Shares Out	8.87%
Short % of Float	12.74%
Short Ratio (days to cover)	2.34

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-203.07M
Pretax Income	-190.77M
Net Income	-190.77M
EBITDA	-203.01M
EBIT	-203.07M
Earnings Per Share (EPS)	-$3.49

Balance Sheet

The company has $324.92 million in cash and n/a in debt, giving a net cash position of $324.92 million or $4.19 per share.

Cash & Cash Equivalents	324.92M
Total Debt	n/a
Net Cash	324.92M
Net Cash Per Share	$4.19
Equity (Book Value)	313.55M
Book Value Per Share	4.77
Working Capital	313.10M

Cash Flow

In the last 12 months, operating cash flow was -$192.69 million and capital expenditures -$37,000, giving a free cash flow of -$192.72 million.

Operating Cash Flow	-192.69M
Capital Expenditures	-37,000
Free Cash Flow	-192.72M
FCF Per Share	-$2.48

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLYS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.20%
Shareholder Yield	-25.20%
Earnings Yield	-5.65%
FCF Yield	-5.70%

Analyst Forecast

The average price target for MLYS is $42.60, which is -2.20% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$42.60
Price Target Difference	-2.20%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1